Privately-held French drugmaker Pierre Fabre Pharmaceuticals says it has reached agreement with the US Food and Drug ...

North Carolina, USA-based clinical-stage gene therapy company Atsena Therapeutics has presented data from three studies at ...

Avalo Therapeutics’ shares surged 34%, after the US clinical-stage biotech announced positive top-line results from its Phase ...

The progressive pulmonary fibrosis market across the seven major markets is forecast to grow from $1.3 billion in 2025 to ...

The US Centers for Medicare & Medicaid Services (CMS) will provide eligible Medicare beneficiaries access to certain GLP-1 ...

US oncology company Citius Oncology (Nasdaq: CTOR) has secured up to $36.5 million in new financing as it attempts to ...

Russia has faced an acute shortage of Abraxane (paclitaxel), a drug, which is produced by US pharma major Bristol-Myers ...

Japanese drugmaker Takeda said its investigational immunoglobulin therapy TAK-881 met the primary endpoint in a pivotal Phase ...

Dutch contract research, development and manufacturing organization Symeres has appointed Henning Steinhagen as chief executive, handing leadership to a drug discovery executive with deep roots in the ...

US biotech Vertex Pharmaceuticals today announced that a reimbursement agreement was signed with the GKV-Spitzenverband for ...

MacroGenics has entered into an expanded royalty purchase agreement with Sagard Healthcare in exchange for a capped royalty ...

Shares of Esperion Therapeutics rocketed 55.5% to $3.11 as the commercial-stage biopharma revealed a takeover bid from ...